Cited by 75Inflammatory Bowel DiseaseGut microbiota and healthImmune Response and Inflammation

Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages

Open access
Toyonaga, Takahiko, Matsuura, Minoru, Mori, Kiyoshi, Honzawa, Yusuke, Minami, Naoki, Yamada, Satoshi, Kobayashi, Taku, Hibi, Toshifumi +1 more·2016·Scientific Reports

Abstract

Lipocalin 2 (Lcn2), also called neutrophil gelatinase B-associated lipocalin (NGAL), is an anti-microbial peptide originally identified in neutrophil granules. Although Lcn2/NGAL expression is increased in the inflamed intestinal tissues of patients with inflammatory bowel disease, the role of Lcn2/NGAL in the development of intestinal inflammation remains unclear. Here we investigated the role of Lcn2/NGAL in intestinal inflammation using a spontaneous mouse colitis model, interleukin-10 knock out (IL-10 KO) mice. Lcn2 expression in the colonic tissues of IL-10 KO mice increased with the development of colitis. Lcn2/IL-10 double-KO mice showed a more rapid onset and development of colitis compared to IL-10 KO mice. Lcn2 enhanced phagocytic bacterial clearance in macrophages in vitro after infection with Escherichia coli. Transfer of Lcn2-repleted macrophages prevented the development of colitis in Lcn2/IL-10 double-KO mice in vivo. Our findings revealed that Lcn2 prevents the development of intestinal inflammation. One crucial factor seems to be the enhancement of phagocytic bacterial clearance in macrophages by Lcn2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep35014

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • By binding enterobactin, NGAL maintains the balance between commensal bacteria and immune cells in the gut where colitogenic bacteria can reside and secrete high amounts of enterobactin into the intestinal lumen.

    “In doing so, NGAL maintains the balance between commensal bacteria and immune cells in the gut where colitogenic bacteria can reside and secrete high amounts of enterobactin into the intestinal lumen (Deriu et al., 2013;Moschen et al., 2016;Toyonaga et al., 2016).”

    From Iron in infection and immunity (2020) · cites this paper as Toyonaga et al., 2016

    The Discussion (page unavailable) says Lcn2/NGAL regulates mucosal immune responses toward enteric commensal bacteria and prevents colitis in IL-10-deficient mice. The introductory passage (page unavailable) describes sequestration of iron-laden bacterial siderophores, but our copy does not identify enterobactin or say that colitogenic bacteria secrete high amounts of it into the intestinal lumen. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Toyonaga, T., Matsuura, M., Mori, K., Honzawa, Y., Minami, N., Yamada, S., Kobayashi, T., Hibi, T., & Nakase, H.
Affiliations
  • Kitasato Institute Hospital (JP)
  • Kyoto University (JP)
  • Shizuoka University (JP)
  • Sapporo Medical University (JP)
Corresponding author
Nakase, Hiroshi
Venue
Scientific Reports
Published
2016-10-13
Volume
6
Issue
1
Pages
35014-35014
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2529902668
Cited by
75
References
49
Citations by year
2026: 5 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 1
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
Funders
  • Ministry of Health, Labour and Welfare
  • Japan Society for the Promotion of Science (26893122, 24590941, 16K09324, 16K19150, 23590940, 16K19365, 26460967)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
neutrophil gelatinase-associated lipocalin, intestinal inflammation, colitis, macrophages, IL-10, Escherichia coli infection, inflammatory bowel disease
MeSH terms
Lipocalin-2, Animals, Colitis, Disease Models, Animal, Escherichia coli, Humans, Macrophages, Phagocytosis, Interleukin-10, Mice, Knockout, Mice, Gene Knockout Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review